KAKKIS EMIL D

CIK 00012480932 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001248093

Recent Transactions

50 trades

Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-03$42.10/sh−73,434→ 641,731 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-01+107,292→ 715,165 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-03-01+43,268→ 607,873 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2025-03-01+78,448→ 78,448 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-02-28$42.48/sh−25,000→ 2,158,985 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-12-30$42.23/sh−11,727→ 2,183,985 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-12-10$50.00/sh−8,273→ 2,195,712 total
Gift
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-12-09−20,000→ 2,203,985 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-09-03$55.85/sh−20,000→ 2,223,985 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-08-06$50.17/sh−20,000→ 2,243,985 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01+38,428→ 578,198 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01$53.69/sh−17,417→ 560,781 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2024-03-01+70,094→ 70,094 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-03-01+3,132→ 563,913 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-02-07$45.00/sh−30,000→ 539,770 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-12-29$47.87/sh−30,000→ 569,770 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-10-19$6.86/sh+47,853→ 647,029 total
Exercise/Conversion
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2023-10-19−47,853→ 0 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-10-19$33.52/sh−47,853→ 599,743 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01+8,716→ 569,406 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2023-03-01+83,500→ 83,500 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01+46,200→ 615,606 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01$45.65/sh−16,140→ 599,176 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-12-30$45.57/sh−19,582→ 541,108 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01$67.37/sh−12,162→ 582,185 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01+52,041→ 634,226 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2022-03-01+92,360→ 92,360 total
Gift
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-12-10−50,000→ 2,209,741 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-10-14$81.00/sh−853→ 594,347 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-05-06$115.71/sh−852→ 595,200 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-05-03$107.80/sh−30,000→ 2,259,741 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-03-01+15,453→ 612,394 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-03-01$142.47/sh−16,342→ 596,052 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-03-01$141.80/sh−30,000→ 2,289,741 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-03-01+36,000→ 36,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-03-01+18,000→ 596,941 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2021-01-04$136.90/sh−30,000→ 2,329,741 total
Gift
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-11-27−31,248→ 578,941 total
Gift
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-11-19−10,000→ 2,349,741 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-11-02$96.82/sh−30,000→ 2,359,741 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-10-14$92.69/sh−852→ 610,189 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-09-01$82.63/sh−30,000→ 2,389,741 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-07-13$85.35/sh−40,000→ 2,419,741 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-06-01$69.38/sh−1,334→ 611,041 total
Gift
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-05-27−40,422→ 578,941 total
Gift
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-05-22−100,000→ 2,349,741 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-05-06$66.26/sh−852→ 652,797 total
Tax Payment
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-04-19$58.57/sh−851→ 653,649 total
Exercise of In-Money
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-03-12$3.01/sh+83,167→ 587,967 total
Exercise of In-Money
Ultragenyx Pharmaceutical Inc.$RARE
Warrant (Right to Buy)
2020-03-12−66,533→ 0 total

Companies

Recent Filings

Address

C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE

NOVATO, CA, 94949

View on SEC.gov